On the other hand, the frequency of effector CD8+CXCR3+CCR5+ T cells was increased in early RA patients compared with HCs (P=0.002) and compared with RA-risk individuals (P=0.04) (Figure 1l). This evidence concerns the gene CD8A and rheumatoid arthritis.